XTSE
EXE
Market cap1.81bUSD
Oct 08, Last price
27.20CAD
1D
-2.12%
1Q
-26.49%
Jan 2017
175.30%
Name
Extendicare Inc
Chart & performance
P/E
26.69
P/S
1.55
EPS
1.02
Div yield, %
1.84%
Shrs. gr., 5y
-0.67%
Rev. gr., 5y
8.51%
Revenues
1.66b
+13.25%
Net income
97m
+28.52%
CFO
165m
+15.02%
Dividend
Sep 29, 20260.0441 CAD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Extendicare Inc. is a leading Canadian provider specializing in a wide range of care and support services for seniors. The company's diverse offerings encompass residential long-term care facilities, various retirement living options, and in-home health support. Its home health care services include essential provisions like professional nursing, specialized occupational, physical, and speech therapies, as well as practical assistance with daily living tasks. Additionally, Extendicare furnishes contract and consulting services to other organizations. The firm operates an extensive network of 119 long-term care homes and retirement communities, alongside its robust home health care divisions, all under well-known brands such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. maintains its headquarters in Markham, Canada.
Related entities
Subsidiaries (6)
EXTENDICARE (CANADA) INC.
Harvest Retirement Community Inc.
ParaMed Inc.
Riverbend Crossing Retirement Community Inc.
Stonebridge Crossing Retirement Community Inc.
Axium Extendicare LTC LP
Key people
David Bacon
Chief Financial Officer, Executive Vice President · since 2024
Mark Trenholm
Senior Vice President - Finance · since 2024
Wendy Gilmour
Senior Vice President - Long-term Care Operations · since 2023
Katie Lemoyne
Chief Human Resource Officer, Senior Vice President · since 2023
Senior Vice President, Chief Legal Officer and Corporate Secretary · since 2019
Steve Paraskevopoulos
Senior Vice President, ParaMed and Chief Technology Officer
Joe Belinsky
Chief Information Officer, Vice President - Information Technology · since 2024
Kathryn Bradley
Vice President - Corporate Development · since 2023
Elaine Everson
Vice President - Redevelopment · since 2023
Jillian Fountain
Vice President of Investor Relations · since 2018
Danielle Parr
Vice President - Public Affairs · since 2024
Matthew Morgan
Chief Medical Officer · since 2020
Michael Guerriere
President, Chief Executive Officer, Director · since 2018
Norma Beauchamp
Independent Director · since 2019
Sandra Hanington
Independent Director · since 2014
Independent Director · since 2016
Brent Houlden
Independent Director · since 2020
Heather-Anne Irwin
Independent Director · since 2025
Donna Kingelin
Independent Director · since 2016
Independent Director · since 2019
Headquarters & legal address
400, 3000 STEELES AVENUE EAST
MARKHAM, ON L3R 4T9
CA
MARKHAM, ON L3R 4T9
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||